Ofatumumab for rheumatoid arthritis

To assess the benefits and harms of ofatumumab in reducing disease activity, pain, and improving function in people with RA.

This is a protocol.

Health topics:

Published:

17 November 2013

Authors:

Anand V, Garg SK, Lopez-Olivo M, Singh JA

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Anand V, Garg SK, Lopez-Olivo M, Singh JA. Ofatumumab for rheumatoid arthritis. Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD010833. DOI: 10.1002/14651858.CD010833